Frontlight ResearchEarly access
CompletedNo phase
rTMS for Stimulant Use Disorders
Key facts
- Who runs it
- Medical University of South Carolina
- Where
- Charleston, Dallas, San Antonio, and Winston-Salem, United StatesSee the 4 sites
- Trial code
- Status
- Completed
- People taking part
- 129 people enrolled
- Started
- 4 Feb 2022
- Ended
- 7 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- rTMS
- Sham (Placebo)
- Record updated
- 3 July 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- 18-65, inclusive
- Have a diagnosis of moderate or severe Cocaine or Methamphetamine Use Disorder (CUD/MUD) over the past 12 months (as determined by DSM-5 diagnostic criteria)
- Have used cocaine or methamphetamine on at least 10 of the last 30 days (based on Timeline Follow-Back)
- Be interested in decreasing cocaine and/or methamphetamine use
- If female, willing to use appropriate birth control method during the treatment phase of the study
- Be able to understand the study procedures and provide written informed consent to participate in the study
- If prescribed benzodiazepines or anticonvulsants, must be on a stable dose for at least 4 weeks prior to consent
Who cannot take part
- Metal implants or non-removable metal objects above the waist
- Lifetime history of prior clinical treatment with TMS
- Previously randomized as a participant in the study
- History of a serious medical disorder that, in the opinion of the Medical Clinician, would make it unsafe to participate in the study or may prevent collection of study data
- Documented history of unprovoked seizure (lifetime) or any seizure in the past 6 months
- Documented history of brain lesion(s) and/or tumor(s)
- Current or lifetime bipolar disorder
- Current psychotic disorder or psychotic depression
- A Diagnostic and Statistical Manual (DSM-5) diagnosis of moderate or severe SUD of any substance other than cocaine or methamphetamine based on DSM-5
- Is currently engaged in formal SUD treatment
- Currently pregnant
- Serious risk of homicide or suicide
- Are a prisoner or in police custody at the time of eligibility screening
- Planned admission to a residential treatment facility or other formal SUD treatment program
- Unwilling or unable to follow study procedures
Where in United States
- Medical University of South CarolinaCharleston, United States
- University of Texas, SouthwesternDallas, United States
- University of Texas Health Science Center San AntonioSan Antonio, United States
- Wake ForestWinston-Salem, United States
About the trial
What the trial wants to find out
The purpose of the study is to determine feasibility of repetitive transcranial magnetic stimulation (rTMS) for individuals with moderate to severe cocaine or methamphetamine use disorder (CUD/MUD). Potential participants will be age 18-65, and interested in cutting down or stopping use. Participants will be randomized to one of two groups; groups will receive rTMS or sham rTMS (placebo) over the course of an 8-week treatment period, and complete follow-up assessments at the end of treatment, 12, and 16 weeks post-randomization.
The 2 groups in the trial
- rTMSExisting treatment, for comparison
Participants will receive up to 30 rTMS sessions within the 8-week treatment period.
- Sham (Placebo)Sham treatment, for comparison
Participants will receive up to 30 sham rTMS sessions within the 8-week treatment period.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- rTMS for Stimulant Use Disorders (CTN-0108)
- Publications
- Repetitive transcranial magnetic stimulation for stimulant use disorders (STIMULUS): protocol for a multi-site, double-blind, randomized controlled trial.Addiction science & clinical practice, 2025
- Record updated
- 3 July 2025